Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Cost of Revenue (2020 - 2025)

NeuroPace (NPCE) has 6 years of Cost of Revenue data on record, last reported at $29.8 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 23.62% year-over-year to $29.8 million; the TTM value through Dec 2025 reached $46.6 million, up 17.42%, while the annual FY2025 figure was $46.6 million, 17.42% up from the prior year.
  • Cost of Revenue reached $29.8 million in Q4 2025 per NPCE's latest filing, up from $6.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $29.8 million in Q4 2025 and bottomed at $2.7 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $6.4 million, with a median of $4.3 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: fell 16.42% in 2022, then surged 440.09% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $2.9 million in 2021, then surged by 36.46% to $4.0 million in 2022, then rose by 12.07% to $4.5 million in 2023, then soared by 440.09% to $24.1 million in 2024, then rose by 23.62% to $29.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $29.8 million in Q4 2025, $6.2 million in Q3 2025, and $5.4 million in Q2 2025.